Elevance Health Declines 20% in 3 Months: Time to Sell the Stock?

Elevance Health, Inc.'s (ELV) shares have lost 20% in the past three months compared with the industry's 7.1% decline. It has also lagged the broader Zacks Medical sector's 3.7% decline and the S&P 500's 10.4% rise in the said time frame. It has a market cap of $95.8 billion. Closing at $425.39 in the last trading session, the stock of the health benefit company stands 25% below its 52- week high of $567.26. Image Source: Zacks Investment Research What's Weighing on Elevance Health's Performance? Elevance H ...